NCI-H2444 Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | NCI-H2444 is a human non-small cell lung cancer (NSCLC) cell line classified within the lung adenocarcinoma spectrum. It was established from a lung tumor specimen obtained from an adult patient and represents an epithelial malignancy of pulmonary origin. As part of large-scale pharmacogenomic and multi-omics characterization efforts, NCI-H2444 has been molecularly profiled alongside extensive panels of human cancer cell lines, enabling integration of genomic, transcriptomic, and pharmacological response data. In comprehensive drug sensitivity studies of over 1,000 cancer cell lines screened against hundreds of anti-cancer compounds, lung cancer models such as NCI-H2444 have been used to correlate oncogenic alterations with therapeutic vulnerabilities :contentReference[oaicite:0]{index=0}. These analyses incorporate somatic mutation profiles, copy number alterations, DNA methylation patterns, and gene expression data to define clinically relevant cancer functional events and associate them with differential drug response. Such datasets allow NCI-H2444 to be positioned within lineage-specific and mutation-driven sensitivity clusters, supporting its application in biomarker discovery and targeted therapy evaluation. Proteomic profiling efforts across hundreds of human cancer cell lines have further expanded the molecular annotation framework applicable to models such as NCI-H2444 :contentReference[oaicite:1]{index=1}. High-resolution mass spectrometry-based quantification of thousands of proteins enables integration of proteome-level measurements with transcriptomic and pharmacological datasets. This systems-level characterization facilitates the identification of protein biomarkers predictive of drug response and supports mechanistic studies of pathway activation, post-transcriptional regulation, and therapeutic resistance in lung adenocarcinoma models. |
|---|---|
| 生物體 | Human |
| 組織 | Lung |
| 疾病 | Lung non-small cell carcinoma |
| 同義詞 | H2444, H-2444, NCIH244 |
特徵
| 年齡 | Age unspecified |
|---|---|
| 性別 | Male |
| 族裔 | Caucasian |
| 形態學 | epithelial |
| 生長特性 | adherent |
監管數據
| 引用 | NCI-H2444 (Cytion catalog number 305904) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_1552 |
生物分子資料
| 突變譜 | Mutation: p.Gly12Val, Homozygous; Mutation: p.Tyr236Cys, Homozygous |
|---|
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305904-291225 | 分析證明書 | 03. Feb. 2026 | 305904 |